scholarly journals The broad-spectrum receptor tyrosine kinase inhibitor dovitinib suppresses growth ofBRAF-mutant melanoma cells in combination with other signaling pathway inhibitors

2015 ◽  
Vol 28 (4) ◽  
pp. 417-430 ◽  
Author(s):  
Casey G. Langdon ◽  
Matthew A. Held ◽  
James T. Platt ◽  
Katrina Meeth ◽  
Pinar Iyidogan ◽  
...  
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Signaling Pathway ◽  
Broad Spectrum ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitor ◽  
Melanoma Cells ◽  
Receptor Tyrosine Kinase Inhibitor

scholarly journals Glomerular Changes in Rats Administered ABT-869, a Multitargeted Receptor Tyrosine Kinase Inhibitor - Linking Ultrastructure to Mechanism

2009 ◽  
Vol 15 (S2) ◽  
pp. 16-17
Author(s):  
J Fagerland ◽  
S Morgan
Keyword(s):  
Tyrosine Kinase ◽  
Tyrosine Kinase Inhibitor ◽  
Receptor Tyrosine Kinase ◽  
Kinase Inhibitor ◽  
Receptor Tyrosine Kinase Inhibitor

Extended abstract of a paper presented at Microscopy and Microanalysis 2009 in Richmond, Virginia, USA, July 26 – July 30, 2009

Sign in / Sign up

Export Citation Format

Share Document